Retinopathy of prematurity and maternal age

Retina

Volumn 30, Issue 2, 2010, Pages 327-331

  Wu, Wei Chi ^a,b   Ong, Frank Shih Chang ^a   Kuo, Jane Zea Chin ^a   Lai, Chi Chun ^a,b   Wang, Ning Chia ^a   Chen, Kuan Jen ^a,b   Hwang, Yih Shiou ^a   Chen, Tun Lu ^a,b   Shih, Chia Pang ^c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Maternal age; Retinopathy of prematurity; Risk factors

Indexed keywords

ADULT; ARTICLE; BIRTH WEIGHT; CASE CONTROL STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; INFANT; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; PREMATURITY; RETINA DETACHMENT; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCLERA BUCKLING PROCEDURE;

ADULT; BIRTH WEIGHT; CASE-CONTROL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; MALE; MATERNAL AGE; ODDS RATIO; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 76749132093     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181ba246f     Document Type: Article

References (38)

1. Brown DR, Biglan AW, Stretavsky MM. Retinopathy of prematurity: the relationship with intraventricular hemorrhage and bronchopulmonary dysplasia. J Pediatr Ophthalmol Strabismus 1990;27:268-271.
2. Darlow BA, Horwood LJ, Clemett RS. Retinopathy of prematurity: risk factors in a prospective population-based study. Paediatr Perinat Epidemiol 1992;6:62-80.
3. Flynn JT, Bancalari E, Snyder ES, et al. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med 1992;326:1050-1054.
4. Hammer ME, Mullen PW, Ferguson JG, Pai S, Cosby C, Jackson KL. Logistic analysis of risk factors in acute retinopathy of prematurity. Am J Ophthalmol 1986;102:1-6.
5. Palmer EA, Flynn JT, Hardy RJ, et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1991;98:1628-1640.
6. Purohit DM, Ellison RC, Zierler S, Miettinen OS, Nadas AS. Risk factors for retrolental fibroplasia: experience with 3,025 premature infants. National Collaborative Study on Patent Ductus Arteriosus in premature infants. Pediatrics 1985;76: 339-344.
7. Allegaert K, de Coen K, Devlieger H. Threshold retinopathy at threshold of viability: the EpiBel study. Br J Ophthalmol 2004;88:239-242.
8. Akkoyun I, Oto S, Yilmaz G, et al. Risk factors in the development of mild and severe retinopathy of prematurity. J AAPOS 2006;10:449-453.
9. Cooke RW, Clark D, Hickey-Dwyer M, Weindling AM. The apparent role of blood transfusions in the development of retinopathy of prematurity. Eur J Pediatr 1993;152:833-836.
10. Shohat M, Reisner SH, Krikler R, Nissenkorn I, Yassur Y, Ben-Sira I. Retinopathy of prematurity: incidence and risk factors. Pediatrics 1983;72:159-163.
11. Schaffer DB, Palmer EA, Plotsky DF, et al. Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1993;100:230-237.
12. Gunn TR, Easdown J, Outerbridge EW, Aranda JV. Risk factors in retrolental fibroplasia. Pediatrics 1980;65:1096-1100.
13. Wallace DK, Kylstra JA, Phillips SJ, Hall JG. Poor postnatal weight gain: a risk factor for severe retinopathy of prematurity. J AAPOS 2000;4:343-347.
14. Watts P, Adams GG, Thomas RM, Bunce C. Intraventricular haemorrhage and stage 3 retinopathy of prematurity. Br J Ophthalmol 2000;84:596-599. (Pubitemid 30339309)
15. Holmstrom G, Thomassen P, Broberger U. Maternal risk factors for retinopathy of prematurity-a population-based study. Acta Obstet Gynecol Scand 1996;75:628-635.
16. Seiberth V, Linderkamp O. Risk factors in retinopathy of prematurity: a multivariate statistical analysis. Ophthalmologica 2000;214:131-135.
17. Watts P, Adams GG. In vitro fertilisation and stage 3 retinopathy of prematurity. Eye 2000;14:330-333. (Pubitemid 30479706)
18. Alonzo AA. Long-term health consequences of delayed childbirth: NHANES III. Womens Health Issues 2002;12:37-45.
19. Sherman SL, Freeman SB, Allen EG, Lamb NE. Risk factors for nondisjunction of trisomy 21. Cytogenet Genome Res 2005;111:273-280.
20. Wladimiroff JW, Bhaggoe WR, Kristelijn M, et al. Sonographically determined anomalies and outcome in 170 chromosomally abnormal fetuses. Prenat Diagn 1995;15:431-438.
21. Glasson EJ, Bower C, Petterson B, de Klerk N, Chaney G, Hallmayer JF. Perinatal factors and the development of autism: a population study. Arch Gen Psychiatry 2004;61:618-627.
22. Hollier LM, Leveno KJ, Kelly MA, McIntire DD, Cunningham FG. Maternal age and malformations in singleton births. Obstet Gynecol 2000;96:701-706.
23. Norton ME. Genetic screening and counseling. Curr Opin Obstet Gynecol 2008;20:157-163.
24. Drazdiené N, Bagdoniené R, Sirtautiené R, Vezbergiené N, Sliesoraitiené V, Sliesoraityté I. Multifactorial risk environment for retinopathy of prematurity. Acta Medica Lituanica 2006;13:141-146.
25. Heffner LJ. Advanced maternal age-how old is too old? N Engl J Med 2004;351:1927-1929.
26. Chervenak JL, Kardon NB. Advancing maternal age: the actual risks. Female Patient 1991;16:17-24.
27. Lamb NE, Yu K, Shaffer J, Feingold E, Sherman SL. Association between maternal age and meiotic recombination for trisomy 21. Am J Hum Genet 2005;76:91-99.
28. Jones KT. Meiosis in oocytes: predisposition to aneuploidy and its increased incidence with age. Hum Reprod Update 2008;14:143-158.
29. Pellestor F, Anahory T, Hamamah S. Effect of maternal age on the frequency of cytogenetic abnormalities in human oocytes. Cytogenet Genome Res 2005;111:206-212.
30. Scala I, Granese B, Sellitto M, et al. Analysis of seven maternal polymorphisms of genes involved in homocysteine/folate metabolism and risk of Down syndrome offspring. Genet Med 2006;8:409-416.
31. Dursun P, Gultekin M, Yuce K, Ayhan A. What is the underlying cause of aneuploidy associated with increasing maternal age? Is it associated with elevated levels of gonadotropins? Med Hypotheses 2006;66:143-147.
32. Loeb LA, Cheng KC. Errors in DNA synthesis: a source of spontaneous mutations. Mutat Res 1990;238:297-304.
33. Wu WC, Drenser K, Trese M, Capone A Jr, Dailey W. Retinal phenotype-genotype correlation of pediatric patients expressing mutations in the Norrie disease gene. Arch Ophthalmol 2007;125:225-230.
34. MacDonald ML, Goldberg YP, Macfarlane J, Samuels ME, Trese MT, Shastry BS. Genetic variants of frizzled-4 gene in familial exudative vitreoretinopathy and advanced retinopathy of prematurity. Clin Genet 2005;67:363-366.
35. Xu Q, Wang Y, Dabdoub A, et al. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 2004;116:883-895.
36. Hutcheson KA, Paluru PC, Bernstein SL, et al. Norrie disease gene sequence variants in an ethnically diverse population with retinopathy of prematurity. Mol Vis 2005;11:501-508.
37. Cooke RW, Drury JA, Mountford R, Clark D. Genetic polymorphisms and retinopathy of prematurity. Invest Ophthalmol Vis Sci 2004;45:1712-1715.
38. Wilding M, Di Matteo L, Dale B. The maternal age effect: a hypothesis based on oxidative phosphorylation. Zygote 2005; 13:317-323.